Medications & Treatments

Lantus competitor Basaglar wins FDA approval

Lantus competitor Basaglar wins FDA approval The Food and Drug Administration on Dec. 16 approved Lilly’s Basaglar (insulin glargine injection 100 unit/mL), a long-acting human…
Pages